Nontuberculous mycobacteria remodel lung microbiota in cystic fibrosis-associated respiratory infections
Nontuberculous mycobacteria remodel lung microbiota in cystic fibrosis-associated respiratory infections
Nontuberculous mycobacterial (NTM) infections in people with cystic fibrosis (pwCF) can have detrimental effects on prognosis and pose significant challenges to treatment. However, there are still questions regarding the contribution and influence of NTMs on the respiratory microbiome and the mechanisms by which NTMs cause infections. Here, we investigate the impact of NTM infection on microbiome composition and lung function (percent predicted forced expiratory volume in 1 second). Primary comparisons were between culture-positive cohorts for Mycobacterium avium complex and Mycobacterium abscessus complex and those who were culture-negative for NTMs and attending outpatient clinics. Additionally, the consequence of cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy status and positive NTM culture was assessed in terms of microbiome change. Our data suggest that the presence of NTM significantly alters the diversity and the composition of the lung microbiota in pwCF, including those receiving CFTR modulator therapies. Importantly, significant associations were detected between NTM presence and changes in abundance of Pseudomonas aeruginosa and Burkholderia cepacia complex members, inferring modulatory effects of NTMs on respiratory microbiomes. This study contributes to the understanding of NTM infection and these organisms' interaction with the respiratory microbiome and CFTR modulator therapy, highlighting the need for further research in this area.IMPORTANCEThe influence of NTM infection in pwCF is still debated, and the extent of their contribution to mortality and morbidity is still questioned. Findings in this study highlight a link between the presence of NTMs and significant alterations in the composition of the respiratory microbiome, particularly with respect to some of the canonical CF pathogens, especially Pseudomonas aeruginosa and members of the Burkholderia cepacia complex. This indicates that complex relationships are occurring within the microbiome. This study further contributes to the understanding of NTM infection in pwCF, with and without CFTR modulator therapy, and highlights the need for further research in this area. The knowledge gained from this study has implications for treatment strategies and management, ultimately aiming to improve and prolong the lives of pwCF.
Adult, Cystic Fibrosis Transmembrane Conductance Regulator, Cystic Fibrosis/microbiology, Female, Humans, Lung/microbiology, Male, Microbiota, Mycobacterium Infections, Nontuberculous/microbiology, Mycobacterium abscessus, Nontuberculous Mycobacteria/isolation & purification, Pseudomonas aeruginosa/isolation & purification, Respiratory Tract Infections/microbiology, Young Adult, respiratory infection, microbiome, Burkholderia cepacia complex, cystic fibrosis, Nontuberculous mycobacterium, CFTR modulator therapy, Pseudomonas aeruginosa
Hardman, Michelle
cf921c23-7100-48f2-a782-4b3c41d304ee
Higgi, Sarah
bdbe36ac-9156-4bc0-85cc-791bce4627d8
Hanson, Liam
f95dc876-0553-4970-ac68-f99bc8f17b0b
Schutz, Kristin
0de502d5-c8b1-4079-b8fd-454e0eaba7c1
Wargo, Matthew J
d8564017-00ae-4c55-a298-d770ebd67a43
Teneback, Charlotte C
cdc44a56-7585-4b67-b350-4201e0d53b22
Daniels, Thomas W V
9a8ab6f0-2eb9-4703-b536-f86923888213
van der Gast, Christopher
eb316b36-8eff-4508-a17a-64fe024d5611
Rivett, Damian W
dd44e46c-42c9-49a1-8ae9-9e1cee01b957
2 September 2025
Hardman, Michelle
cf921c23-7100-48f2-a782-4b3c41d304ee
Higgi, Sarah
bdbe36ac-9156-4bc0-85cc-791bce4627d8
Hanson, Liam
f95dc876-0553-4970-ac68-f99bc8f17b0b
Schutz, Kristin
0de502d5-c8b1-4079-b8fd-454e0eaba7c1
Wargo, Matthew J
d8564017-00ae-4c55-a298-d770ebd67a43
Teneback, Charlotte C
cdc44a56-7585-4b67-b350-4201e0d53b22
Daniels, Thomas W V
9a8ab6f0-2eb9-4703-b536-f86923888213
van der Gast, Christopher
eb316b36-8eff-4508-a17a-64fe024d5611
Rivett, Damian W
dd44e46c-42c9-49a1-8ae9-9e1cee01b957
Hardman, Michelle, Higgi, Sarah, Hanson, Liam, Schutz, Kristin, Wargo, Matthew J, Teneback, Charlotte C, Daniels, Thomas W V, van der Gast, Christopher and Rivett, Damian W
(2025)
Nontuberculous mycobacteria remodel lung microbiota in cystic fibrosis-associated respiratory infections.
Microbiology Spectrum, 13 (9), [e0038225].
(doi:10.1128/spectrum.00382-25).
Abstract
Nontuberculous mycobacterial (NTM) infections in people with cystic fibrosis (pwCF) can have detrimental effects on prognosis and pose significant challenges to treatment. However, there are still questions regarding the contribution and influence of NTMs on the respiratory microbiome and the mechanisms by which NTMs cause infections. Here, we investigate the impact of NTM infection on microbiome composition and lung function (percent predicted forced expiratory volume in 1 second). Primary comparisons were between culture-positive cohorts for Mycobacterium avium complex and Mycobacterium abscessus complex and those who were culture-negative for NTMs and attending outpatient clinics. Additionally, the consequence of cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy status and positive NTM culture was assessed in terms of microbiome change. Our data suggest that the presence of NTM significantly alters the diversity and the composition of the lung microbiota in pwCF, including those receiving CFTR modulator therapies. Importantly, significant associations were detected between NTM presence and changes in abundance of Pseudomonas aeruginosa and Burkholderia cepacia complex members, inferring modulatory effects of NTMs on respiratory microbiomes. This study contributes to the understanding of NTM infection and these organisms' interaction with the respiratory microbiome and CFTR modulator therapy, highlighting the need for further research in this area.IMPORTANCEThe influence of NTM infection in pwCF is still debated, and the extent of their contribution to mortality and morbidity is still questioned. Findings in this study highlight a link between the presence of NTMs and significant alterations in the composition of the respiratory microbiome, particularly with respect to some of the canonical CF pathogens, especially Pseudomonas aeruginosa and members of the Burkholderia cepacia complex. This indicates that complex relationships are occurring within the microbiome. This study further contributes to the understanding of NTM infection in pwCF, with and without CFTR modulator therapy, and highlights the need for further research in this area. The knowledge gained from this study has implications for treatment strategies and management, ultimately aiming to improve and prolong the lives of pwCF.
Text
hardman-et-al-2025-nontuberculous-mycobacteria-remodel-lung-microbiota-in-cystic-fibrosis-associated-respiratory
- Version of Record
More information
Accepted/In Press date: 29 June 2025
e-pub ahead of print date: 31 July 2025
Published date: 2 September 2025
Keywords:
Adult, Cystic Fibrosis Transmembrane Conductance Regulator, Cystic Fibrosis/microbiology, Female, Humans, Lung/microbiology, Male, Microbiota, Mycobacterium Infections, Nontuberculous/microbiology, Mycobacterium abscessus, Nontuberculous Mycobacteria/isolation & purification, Pseudomonas aeruginosa/isolation & purification, Respiratory Tract Infections/microbiology, Young Adult, respiratory infection, microbiome, Burkholderia cepacia complex, cystic fibrosis, Nontuberculous mycobacterium, CFTR modulator therapy, Pseudomonas aeruginosa
Identifiers
Local EPrints ID: 506880
URI: http://eprints.soton.ac.uk/id/eprint/506880
ISSN: 2165-0497
PURE UUID: 7ab29e80-ffbe-49db-a0bc-84ec72875d50
Catalogue record
Date deposited: 19 Nov 2025 17:44
Last modified: 19 Nov 2025 17:45
Export record
Altmetrics
Contributors
Author:
Michelle Hardman
Author:
Sarah Higgi
Author:
Liam Hanson
Author:
Kristin Schutz
Author:
Matthew J Wargo
Author:
Charlotte C Teneback
Author:
Thomas W V Daniels
Author:
Christopher van der Gast
Author:
Damian W Rivett
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics